World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

MUTATIONS RESPONSIBLE FOR CLINICAL PHENOTYPES OF COLLODION BABIES: AN OVERVIEW

Mohammad Farhan Qureshi, Mohammed Khalaf AlMutairi, Viquar Fatima Qureshi and Shoeb Qureshi*

ABSTRACT

Collodion baby is a descriptive term for infants who are born in a tight shiny membrane (like a plastic wrap) caused by developmental dysfunction in the epidermis. In almost all such cases, different forms of ichthyosiform diseases and the changing phenotypes of icthyosis (bullous and non-bullous ichthyosis, lamellar and arthrogryposis, self-healing and improving ichthyosis, bathing suit ichthyosis, loricrin keratoderma, trichothiodystrophy, harlequin ichthyosis, icthyosis vulgaris, ichthyosiform erythroderma) are implicated under the influence of different genes (TGM1, ABCA 12, KRT10, CYP4F22, ARCI, loricrin gene) and their mutations (984+1G>A, c.1857delA, c.5653-5655deITAT, 467G.A, ALOXE3, ALOX12, ALOX12B, c.1922_1926+2 delGGCCTGT, p.Val359Met, G278R, D490G, G278R, c.420A>G, c.832G>A, c.141G>T, P.W47C, p.Arg396His, P.N171Tfs(*)45). To accomplish the target, peer-reviewed English language articles published up to 2016 were selected from Pub Med, Pub Med Central, Science Direct, Up-to-date, Med Line, comprehensive databases, Cochrane library, Google and yahoo. Literature reports confirm that when membrane cracks the CBs are exposed to a higher risk of complications including loss of fluid, dehydration, instability in body temperature, electrolyte imbalance, morbidity and mortality. Thus they are placed within a chamber of high humidity for gradual sloughing off of the membrane. Besides, regular and symptomatic treatment, identification of genes and their mutations is crucial for gene therapy.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR